Toxic interactions of Romiplostim and Rituximab in normal and thrombocytopenic Rats
Immune thrombocytopenia (ITP) is an autoimmune disorder characterized by immunologic destruction of normal platelets and insufficient production of platelets mediated by autoantibodies. And there are different treatment options for management of thrombocytopenia according to each case. Because of th...
Guardado en:
Autores principales: | Saeed H., Sayed H.M., Ramadan A., Nahla S. Kotb |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Egyptian Society for Animal Management
2020
|
Materias: | |
Acceso en línea: | https://dx.doi.org/10.21608/javs.2019.20470.1000 https://doaj.org/article/40c8ab91f9484ff08280bb1be8c50ce7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Practice Guidelines of the Central European Hepatologic Collaboration (CEHC) on the Use of Thrombopoietin Receptor Agonists in Patients with Chronic Liver Disease Undergoing Invasive Procedures
por: Robert Flisiak, et al.
Publicado: (2021) -
Rapid response to mycophenolate mofetil in combination with romiplostim in a case of severe refractory immune thrombocytopenia post COVID‐19 vaccination
por: Snigdha Nutalapati, et al.
Publicado: (2021) -
First report on health-related quality of life among children with chronic immune thrombocytopenia in Vietnam
por: Sang Ngoc Nguyen, PhD, et al.
Publicado: (2021) -
The pathophysiology of thrombocytopenia in chronic liver disease
por: Mitchell O, et al.
Publicado: (2016) -
Dentoalveolar Procedures in Immune Thrombocytopenia; Systematic Review and an Institutional Guideline
por: Wobke E. M. van Dijk, et al.
Publicado: (2021)